Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer [NA]
This clinical trial update reports completed results evaluating tumor markers for the efficacy of a dual-target therapy in HER2-positive bre…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors [Phase 1]
Phase 1 trial of ZN-A-1041 enteric capsules in HER2-positive advanced solid tumors has completed. The study enrolled patients with HER2-posi…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy [Phase 2]
A Phase 2 study evaluating whether tumor bed boost radiotherapy can be omitted for patients achieving pathologic complete response after bre…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: FErtility, PrEgnancy, contRaceptIon After Breast Cancer in France
A French study assessing fertility, pregnancy, and contraception after breast cancer treatment has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Effect of Dietary Counseling and Nutritional Monitoring in Reducing Cancer-related Cachexia Among Female Oncology Patients [NA]
A completed clinical trial evaluating dietary counseling and nutritional monitoring to reduce cancer-related cachexia in female breast cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC) [Phase 3]
Phase 3 trial evaluating trastuzumab emtansine in combination with atezolizumab or placebo for HER2-positive, PD-L1-positive locally advance…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Study to Evaluate CCS1477 in Advanced Tumours [Phase 1, Phase 2]
A Phase 1/2 study of CCS1477 has completed, evaluating it in metastatic castration-resistant prostate cancer and metastatic breast cancer, w…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 [NA]
Phase 2 trial investigating an end-of-life conversation game to engage cancer patients in advance care planning; the study is currently acti…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: [18F]FES PET/CT in Endocrine Refractory Breast Cancer [Phase 2]
Phase 2 trial evaluating [18F]fluoroestradiol PET/CT imaging in estrogen receptor-positive breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Efficacy and Safety of T-DXd in Patients With HER2-positive and HER2-low Metastatic Breast Cancer: a Real-world Study
This real-world study updates the efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients with HER2-positive and HER2-low metastat…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer [Phase 1]
Phase 1 trial evaluating cirmtuzumab in combination with paclitaxel for metastatic or locally advanced, unresectable breast cancer has compl…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: A Phase 1 Study of AZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast Cancer [Phase 1]
This is an update on a Phase 1 study of AZD9833 in Japanese women with ER-positive, HER2-negative advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating rifaximin to treat gastrointestinal toxicities related to pertuzumab-based therapy in patients with stage …
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Adjustable Compression Wraps (ACW) in Lymphedema [NA]
A completed clinical trial evaluated Adjustable Compression Wraps for lymphedema, including arm lymphedema and breast-cancer–associated case…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Real-life Pan-HER-blockade With Neratinib
This clinical trial update reports a completed real-world study of neratinib used for pan-HER blockade in breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer [Phase 3]
A Phase 3 trial is evaluating GM1 as a preventive treatment to reduce nab-paclitaxel–associated chemotherapy-induced peripheral neuropathy i…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Messaging Intervention to Increase Medicare Annual Wellness Visits -- The NUDGE AWV Clinical Trial [NA]
The trial evaluated a messaging intervention to increase Medicare Annual Wellness Visits and cancer screenings (breast and colorectal) and i…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Systematic Intervention to Improve Sexual Dysfunction [NA]
A clinical trial is currently RECRUITING to test a systematic intervention aimed at improving sexual dysfunction in patients with breast can…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Safety Study of 3D Printing Personalized Biodegradable Implant for Breast Reconstruction [Phase 1]
This clinical trial update notes the completion of a Phase 1 safety study evaluating a 3D-printed personalized biodegradable implant for bre…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Metastatic Breast Cancer-Specific Prognostic Tool
This trial update notes the completion of a study evaluating a prognostic tool for metastatic breast cancer. The snippet does not provide ef…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Breast Cancer Survivors RESET (Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools): A Pilot, Feasibility Study [NA]
This document describes a pilot feasibility clinical trial called RESET, which aims to reduce weight and elevated stress levels in breast ca…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Study of DM5167 in Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 study evaluates DM5167 in patients with advanced breast cancer and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI [NA]
A completed clinical trial comparing sentinel lymph node biopsy (SNB) to PET/MRI for axillary staging in node-positive breast cancer patient…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR) [NA]
The ALLSTAR trial is a randomized study evaluating strategies to increase physical activity in Black and Hispanic survivors of breast and pr…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Proof of Concept of the Aiinane Preoperative Risk Assessment Tool.
The study completed a proof-of-concept evaluation of the Aiinane Preoperative Risk Assessment Tool in women scheduled for breast cancer surg…